Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Arthritis, Rheumatoid × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urologic Diseases 1 Nephritis 1 Kidney Diseases 1 Immune System Diseases 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Etanercept 9 Adalimumab 9 Methotrexate 3 Infliximab 3 tofacitinib 2 Leflunomide 2 Abatacept 2 tocilizumab 1 sarilumab 1 golimumab 1 entecavir 1 Tumor Necrosis Factor Inhibitors 1 Sulfasalazine 1 Rituximab 1 Prednisone 1 Licensure 1 Hydroxychloroquine 1 Glucocorticoids 1 Folic Acid 1 Chloroquine 1 Certolizumab Pegol 1 Azathioprine 1 Antirheumatic Agents 1 Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡